Dynavax Technologies Deal History & Licensing Activity
Dynavax Technologies is a biotech headquartered in US. Over the past three years, Dynavax Technologies has been involved in 2 licensing and acquisition transactions, with a primary focus on Vaccines (4 deals). The company currently has 2 active clinical trials, primarily in Mega Deals.
Deals (12mo)
1
Active Trials
2
Top Modality
Vaccines
Focus Area
Mega Deals
Dynavax Technologies Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Dynavax Technologies in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Vaxart vaccines platform | Dynavax | Vaccines | Unknown | collaboration | Jul 15, 2026 |
| Dynavax adjuvant and vaccine portfolio | Sanofi | Vaccines | Unknown | acquisition | Jun 15, 2026 |
Dynavax Technologies Pipeline Focus
Therapeutic areas and modalities where Dynavax Technologies is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Dynavax Technologies Strategic Signals
Key indicators of Dynavax Technologies's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Dynavax Technologies Clinical Pipeline
Dynavax Technologies has 2 active clinical trials across 2 development phases.
1
Phase 1
1
Phase 2
See How Your Asset Matches Dynavax Technologies's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
Vaccines Benchmarks
Upfront, milestone, and royalty benchmarks for vaccines deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Dynavax Technologies Licensing & Deal Activity
Dynavax Technologies is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Dynavax Technologies ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Dynavax Technologies include Mega Deals (2 deals and trials), Immunology (2 deals and trials), and Infectious (1 deal and trial). In terms of modality, Dynavax Technologies has shown particular interest in vaccines.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Dynavax Technologies and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Dynavax Technologies's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.